已收盘 08-07 16:00:00 美东时间
+4.460
+2.80%
Zhengye Biotechnology stock plunges after a 322% rally as the company finds no undisclosed catalyst and contacts Nasdaq.
07-22 23:59
Repligen to acquire BioLife Solutions for $1.5B to boost cell therapy bioprocessing capabilities and expand global reach.
07-22 21:41
Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced the grand opening of its new Repligen Training & Innovation Center ("RTIC") at its
04-17 19:35
Repligen (NASDAQ:RGEN) is set to give its latest quarterly earnings report on T...
02-24 00:01
In the preceding three months, 5 analysts have released ratings for Repligen (N...
01-17 04:00
Repligen Corp's (NYSE:RGEN) short interest as a percent of float has risen 23.0...
2025-12-10 21:00
Companies Reporting Before The Bell • PayPal Holdings (NASDAQ:PYPL) is expected...
2025-10-28 19:11
(来源:抗体圈) 生物工艺,突破瓶颈 一次性系统(SUS)已成为生物制药工艺的变革力量,为传统不锈钢设备提供了替代方案。这些一次性预...
2025-09-25 08:36
为了实现零排放的未来,汽车行业迫切需要重塑。我们今天所了解和驾驶的燃油车历经了数十年的演变发展。新型电动汽车的舒适度、驾驶体验、耐用期限和安全性应能够与燃油车相...
2025-07-09 13:38
Repligen Corporation released its 2024 Corporate Sustainability Report themed "Perspectives on Progress," highlighting achievements in six key impact areas and aligning with global sustainability frameworks. The report underscores the company's commitment to sustainability and business resilience, with notable progress in renewable energy, waste reduction, and community engagement.
2025-05-27 11:30